X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II

Immunity

Volumn 7, Issue 4, 1997, Pages 473-481

  Dessen, Andréa ^a   Lawrence, C Martin ^a   Cupo, Susan ^c   Zaller, Dennis M ^c   Wiley, Don C ^a,b  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD UNIVERSITY   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 2; HLA DR4 ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN BINDING; ARTICLE; CRYSTAL STRUCTURE; GENETIC PREDISPOSITION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; X RAY CRYSTALLOGRAPHY;

EID: 0030701632     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(00)80369-6     Document Type: Article

References (54)

1. Banerjee, S., Luthra, H.S., Moore, S.B., and O'Fallon, W.M. (1988). Serum IgG anti-native type II collagen antibodies in rheumatoid arthritis: association with HLA DR4 and lack of clinical correlation. Clin. Exp. Rheumatol. 6, 373-380.
2. Barber, L.D., Bal, V., Lamb, J.R., O'Hehir, R.E., Yendle, J., Hancock, R.J.T., and Lechler, R.I. (1991). Contribution of T-cell receptor-contacting and peptide-binding residues of the class II molecule HLA-DR4 to serologic and antigen-specific T-cell recognition. Human Immunol. 32, 110-118.
3. Brown, J.H., Jardetzky, T.S., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1993). Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364, 33-39.
4. Brünger, A.T. (1992). Free R value: a novel statistical quantity for assessing the accuracy of crystal structures. Nature 355, 472-475.
5. Bunch, T.A., Grunblat, Y., and Goldstein, L.S.B. (1988). Characterization and use of the Drosophila metallothionein promoter in cultured Drosophila melanogaster cells. Nucleic Acids Res. 16, 1043-1061.
6. Busch, R., Hill, C.M., Hayball, J.D., Lamb, J.R., and Rothbard, J.B. (1991). Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding. J. Immunol. 147, 1292-1298.
7. Demotz, S., Barbey, C., Corradin, G., Amoroso, A., and Lanzavecchia, A. (1993). The set of naturally processed peptides displayed by DR molecules is tuned by polymorphism of residue 86. Eur. J. Immunol. 23, 425-432.
8. Feldman, M., Brennan, F.M., and Maini, R.V. (1996). Rheumatoid arthritis. Cell 85, 307-310.
9. Fremont, D.H., Hendrickson, W.A., Marrack, P., and Kappler, J. (1996). Structures of an MHC class II molecule with covalently bound single peptides. Science 272, 1001-1004.
10. Fu, X.T., Bono, C.P., Woulfe, S.L., Swearingen, C., Summers, N.L., Sinigaglia, F., Sette, A., Schwartz, B.D., and Karr, R.W. (1995). Pocket 4 of the HLA-DR(alpha,beta 1*0401)molecule is a major determinant of T cells recognition of peptide. J. Exp. Med. 181, 915-926.
11. Fugger, L., Michie, S.A., Rulifson, I., Lock, C.B., and McDevitt, G.S. (1994). Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response. Proc. Natl. Acad. Sci. USA 91, 6151-6155.
12. Fugger, L., Rothbard, J.B., and Sonderstrup-McDevitt, G. (1996). Specificity of an HLA-DRB1*0401-restricted T cell response to type II collagen. Eur. J. Immunol. 26, 928-933.
13. Garboczi, D.N., Ghosh, P., Utz, U., Fan, Q.R., Biddison, W.E., and Wiley, D.C. (1996a). Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141.
14. Garboczi, D.N., Utz, U., Ghosh, P., Seth, A., Kim, J., van Tienhoven, A.E., Biddison, W.E., and Wiley, D.C. (1996b). Assembly, specific binding, and crystallization of a human TCR-αβ with an antigenic Tax peptide from human T lymphotropic virus type 1 and the class I MHC molecule HLA-A2. J. Immunol. 157, 5403-5410.
15. Garcia, K.C., Degano, M., Stanfield, R.L., Brunmark, A., Jackson, M.R., Peterson, P.A., Teyton, L., and Wilson, I.A. (1996). An αβ T cell receptor structure at 2.5Å and its orientation in the TCR-MHC complex. Science 274, 209-219.
16. Ghosh, P., Amaya, M., Mellins, E., and Wiley, D.C. (1995). The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
17. Gorga, J.C., Brown, J.H., Jardetzky, T., Wiley, D.C., and Strominger, J.L. (1991). Crystallization of HLA-DR antigens. Res. Immunol. 142, 401-407.
18. Gregersen, P.K., Silver, J., and Winchester, R.J. (1987). The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205-1213.
19. Hammer, J., Takacs, B., and Sinigaglia, F. (1992). Identification of a motif for HLA-DrI binding peptides using M13 display libraries. J. Exp. Med. 776, 1007-1013.
20. Hammer, J., Valsasnini, P., Tolba, K., Bolin, D., Higelin, J., Takacs, B. and Sinigaglia, F. (1993). Promiscuous and allele-specific anchors in HLA-DR-binding peptides. Cell 74, 197-203.
21. Hammer, J., Belunis, C., Bolin, D., Papadopoulos, J., Walsky, R., Higelin, J., Danho, W., Sinigaglia, F., and Nagy, Z.A. (1994). High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. Proc. Natl. Acad. Sci. USA 91, 4456-4460.
22. Hammer, J., Gallazzi, F., Bono, E., Karr, R.W., Guenot, J., Valsasnini, P., Nagy, Z.A., and Sinigaglia, F. (1995). Peptide binding specificity of HLA-DR4 molecules: correlation with rheumatoid arthritis association. J. Exp. Med. 181, 1847-1855.
23. Hiraiwa, A., Yamanaka, K., Kwok, W.W., Mickelson, E.M., Masewicz, S., Hansen, J.A., Radka, S.F., and Nepom, G.T. (1990). Structural requirements for recognition of the HLA-Dw14 class II epitope: a key HLA determinant associated with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 87, 8051-8055.
24. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Chi, Y.I., Stauffacher, C., Strominger, J.L., and Wiley, D.C. (1994). Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen. Nature 368, 711-718.
25. Jardetzky, T.S., Brown, J.H., Gorga, J.C., Stern, L.J., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1996). Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. Natl. Acad. Sci. USA 93, 734-738.
26. Jasin, H.E. (1985). Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum. 28, 241-248.
27. Jones, T.A., Zou, J.Y., Cowan, S.W., and Kjeldgaard. (1991). Improved methods for binding protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A 47, 110-119.
28. Khare, S.D., Krco, C.J., Griffiths, M.M., Luthra, H.S., and David, C.S. (1995). Oral administration of an immunodominant human collagen peptide modulates collagen-induced arthritis. J. Immunol. 155, 3653-3659.
29. Lanchbury, J.S., Jaeger, E.E., Sansom, D.M., Hall, M.A., Wordsworth, P., Stedeford, J., Bell, J.I., and Panayi, G.S. (1991). Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. Hum. Immunol. 32, 56-64.
30. Londei, M., Savill, C.M., Verhoef, A., Brennan, F., Leech, Z.A., Duance, V., Maini, R.N., and Feldman, M. (1989). Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 86, 636-640.
31. Mengle-Gaw, L., Conner, S., McDevitt, H.O., and Fathman, C.G. (1984). Gene conversion between murine class II major histocompatibility complex loci: functional and molecular evidence from the bm 12 mutant. J. Exp. Med. 160, 1184-1194.
32. Nepom, G.T., and Erlich, H. (1991). MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9, 493-525.
33. Nepom, G.T., Byers, P., Seyfried, C., Healey, L.A., Wilske, K.R., Stage, D., and Nepom, B.S. (1989). HLA genes associated with rheumatoid arthritis: identification of susceptibility alleles using specific oligonucleotide probes. Arthritis Rheum. 32, 15-21.
34. Newton-Nash, O.K., and Eckels, D.D. (1993). Differential effect of polymorphism at HLA-DR1 beta-chain positions 85 and 86 on binding and recognition of DR1-restricted antigenic peptides. J. Immunol. 150, 1813-1821.
35. Otwinowski, Z. (1993). In Proceedings of CCP4 Study Weekend: Data Collection and Processing, L. Sawyer, N. Isaacs, S. Bailey, eds. (Warrington, UK: SERC Daresbury Laboratory), pp. 56-62.
36. Rammensee, H.G., Friede, T., and Stevanoviic, S. (1995). MHC ligands and peptide motifs: first listing, Immunogenetics 41, 178-228.
37. Rosloniec, E.F., Brand, D.D., Myers, L.K., Whittington, K.B., Gumanovskaya, M., Zaller, D.M., Woods, A., Altmann, D.M., Stuart, J.M., and Kang, A.H. (1997). An HLA-DR1 transgeneconfers susceptibility to collagen-induced arthritis elicited with human type II collagen. J. Exp. Med. 185, 1113-1122.
38. Signorelli, K.L., Watts, L.M., and Lambert, L.E. (1995). The importance of DR4Dw4 beta chain residues 70, 71, and 86 in peptide binding and T cell recognition. Cell. Immunol. 162, 217-224.
39. Silver, J., and Goyert, S.M. (1985). Epitopes Are the Functional Units of la Molecules and Form the Molecular Basis for Disease Susceptibility (Berlin: Springer-Verlag).
40. Steere, A.C., Dwyer, E., and Winchester, R. (1990). Association of chronic Lyme arthritis with HLA-DR4 and HLA-DR2 alleles. N. Engl. J. Med. 323, 219-223.
41. Stellar, H., and Pirrotta, V. (1985). A transposable P vector that confers selectable G418 resistance to Drosophila larvae. EMBO J. 4, 167-171.
42. Stern, L.J., and Wiley, D.C. (1994b). Antigenic peptide binding by class I and class II histocompatibility proteins. Structure 2, 245-251.
43. Stern, L.J., Brown, J.H., Jardetzky, T.S., Gorga, J.C., Urban, R.G., Strominger, J.L., and Wiley, D.C. (1994a). Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
44. 125L-radioimmunoassay. Arthritis Rheum. 26, 832-840.
45. Swaminathan, S., Furey, W., Pletcher, J., and Sax, M. (1992). Crystal structure of staphylococcal enterotoxin B, a superantigen. Nature 359, 801-806.
46. Terato, K., Shimozuru, Y., Katayama, K., Takemitsu, Y., Yamashita, I., Miyatsu, M., Fujii, K., Sagara, M., Kobayashi, S., and Goto, M., et al. (1990). Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 33, 1493-1500.
47. Tiwari, J., and Terasaki, P. (1985). HLA and Disease Association. (New York: Springer-Verlag).
48. Todd, J.A., Acha-Orbea, H., Bell, J.I., Chao, N., Fronek, Z., Jacob, C.O., McDermott, M., Sinha, A.A., Timmerman, L., Steinman, L., et al. (1988). A molecular basis for MHC class II-associated autoimmunity [published erratum appears in Science, 241, 888, 1988]. Science 240, 1003-1009.
49. Verreck, F.A., Termijtelen, A., and Koning, F. (1993). HLA-DR beta chain residue 86 controls DR alpha beta dimer stability. Eur. J. Immunol. 23, 1346-1350.
50. Watson, W., Cremer, M., Wooley, P., and Townes, A. (1986). Assessment of the potential pathogenicity of type II collagen autoantibodies in patients with rheumatoid arthritis. Arthritis Rheum. 29, 1316-1321.
51. Woulfe, S.L., Bono, C.P., Zacheis, M.L., Kirschmann, D.A., Baudino, T.A., Swearingen, C., Karr, R.W., and Schwartz, B.D. (1995). Negatively charged residues interacting with the p4 pocket confer binding specificity to DRB1*0401. Arthritis Rheum. 38, 1744-1753.
52. Wucherpfennig, K.W., and Strominger, J.L. (1995). Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases. J. Exp. Med. 181, 1597-1601.
53. Zanelli, E., Gonzalez-Gay, M.A., and David, C.S. (1995). Could HLA-DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today 16, 274-278.
54. Zanelli, E., Krco, C.J., Baisch, J.M., Cheng, S., and David, C.S. (1996). Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93, 1814-1819.